MedPage Today reports that the FDA has approved duloxetine (Cymbalta), an SNRI (serotonin-norepinphrine reuptake inhibitor), for fibromyalgia (FMS).
This is only the second drug to be approved for FMS. Last year the the FDA approved the anti-seizure drug pregabalin (Lyrica) for FMS.
Click to continue reading “FDA Approves Another Drug for Fibromyalgia”


